CVSA Stock Forecast & Price Target

Covista is supported by a fundamentally stronger mix than most online education peers, with healthcare-heavy programs and domestic operations reducing its exposure to the AI-driven student-acquisition pressure that is weighing on the broader group. Recent operating results reinforced that edge, as total revenues rose 5% year over year to $487M with Chamberlain at $197M, Walden at $187M, and Med/Vet at $103.5M, while Chamberlain enrollment returned to growth at 40.8k, up 0.5% year over year, and showed signs of sustainable reacceleration through two consecutive quarters of double-digit application growth, normalized conversion, and 15 straight quarters of pre-licensure growth. Even with a more difficult setup over the next 12 months because of AI overhang and new loan caps, the company’s segment momentum, especially Walden’s scale and Chamberlain’s improving execution, suggests it should continue to outperform public peers fundamentally and remain resilient if enrollment trends and corporate partnerships continue to strengthen.

Covista is viewed negatively because the stock already appears to reflect an expected Chamberlain re-acceleration, leaving less room for multiple expansion and making it difficult to justify a move back toward prior peak valuations, especially as sector multiples may remain capped below 5-year averages in the near term. The outlook is also pressured by external risks, including forecasted Republican losses in the midterms, which may weigh on politically correlated sector sentiment, and new loan caps effective 7/1, which could reduce Med/Vet demand over the coming years. Although the company reported solid current results with adjusted EBITDA of $128M versus $117M consensus and adjusted EPS of $1.98, the fundamental issue is that FY27 upside appears constrained by heavy Chamberlain campus expansion, which should support long-term growth but initially dilutes margins, while the company’s FY27 targets of revenue growth of 6-8% and EBITDA margin of 0-50 bps leave only modest room for sustained re-rating.